UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
1351
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.78M | ﹤0.01% |
48,295
+9,159
| +23% | +$498K |
|
1352
Watts Water Technologies
WTS
$13.1B
| $2.78M | ﹤0.01% |
34,289
+938
| +3% | +$75.6K |
|
1353
Merit Medical Systems
MMSI
$5.32B
| $2.77M | ﹤0.01% |
60,779
+6,822
| +13% | +$275K |
|
1354
Cleveland-Cliffs
CLF
$6.99B
| $2.77M | ﹤0.01% |
501,618
-38,217
| -7% | -$186K |
|
1355
Acadia Healthcare
ACHC
$2.94B
| $2.76M | ﹤0.01% |
109,961
-18,380
| -14% | -$459K |
|
|
MIME
1356
DELISTED
Mimecast Limited
MIME
| $2.76M | ﹤0.01% |
66,291
+6,943
| +12% | +$273K |
|
1357
Bloom Energy
BE
$64.6B
| $2.76M | ﹤0.01% |
253,283
+196,351
| +345% | +$1.53M |
|
1358
OneMain Financial
OMF
$7.47B
| $2.75M | ﹤0.01% |
112,145
-5,751
| -5% | -$131K |
|
|
VISN
1359
Vistance Networks Inc
VISN
$2.52B
| $2.75M | ﹤0.01% |
330,015
-61,921
| -16% | -$611K |
|
1360
Insperity
NSP
$2.01B
| $2.74M | ﹤0.01% |
42,327
+2,789
| +7% | +$140K |
|
1361
Vertiv
VRT
$105B
| $2.73M | ﹤0.01% |
+201,009
| New | +$2.34M |
|
1362
Synaptics
SYNA
$4.15B
| $2.72M | ﹤0.01% |
45,179
+12,813
| +40% | +$803K |
|
|
IRBT
1363
DELISTED
iRobot
IRBT
| $2.71M | ﹤0.01% |
32,311
+9,645
| +43% | +$635K |
|
1364
MGE Energy Inc
MGEE
$3.08B
| $2.71M | ﹤0.01% |
41,953
-1,544
| -4% | -$101K |
|
|
IBKC
1365
DELISTED
IBERIABANK Corp
IBKC
| $2.7M | ﹤0.01% |
59,303
-1,717
| -3% | -$70.9K |
|
1366
Howard Hughes
HHH
$4.03B
| $2.7M | ﹤0.01% |
54,503
+298
| +0.5% | +$15K |
|
1367
Navient
NAVI
$853M
| $2.7M | ﹤0.01% |
383,843
-6,348
| -2% | -$47.2K |
|
1368
Independent Bank
INDB
$3.97B
| $2.7M | ﹤0.01% |
40,182
-584
| -1% | -$39.3K |
|
|
BMCH
1369
DELISTED
BMC Stock Holdings, Inc
BMCH
| $2.69M | ﹤0.01% |
106,839
-26,271
| -20% | -$581K |
|
1370
Sensient Technologies
SXT
$5.53B
| $2.69M | ﹤0.01% |
51,482
+2,739
| +6% | +$130K |
|
1371
ABM Industries
ABM
$2.84B
| $2.67M | ﹤0.01% |
73,658
+6,838
| +10% | +$222K |
|
1372
Olin
OLN
$2.12B
| $2.66M | ﹤0.01% |
231,076
-24,917
| -10% | -$317K |
|
1373
Ecopetrol
EC
$34.5B
| $2.65M | ﹤0.01% |
237,939
-2,600
| -1% | -$28.2K |
|
1374
Tanger
SKT
$4.52B
| $2.62M | ﹤0.01% |
367,194
-26,919
| -7% | -$178K |
|
|
TPH
1375
DELISTED
Tri Pointe Homes
TPH
| $2.61M | ﹤0.01% |
177,848
-4,090
| -2% | -$50.1K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.